| ²é¿´: 1353 | »Ø¸´: 1 | ||
fengtingtiͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖú£º¹ØÓÚRamos cells (CRL-1596, B-cell, human Burkitt¡¯s lymphoma)Éú³¤ÐÎòͼ£¿
|
|
´ó¼ÒºÃ£¬ÇëÎÊÓÐÖªµÀRamos cells (CRL-1596, B-cell, human Burkitt¡¯s lymphoma) µÄϸ°û³ÉÏñͼƬÂð£¿ÊÇʲôÐÎ×´£¿ÊÇÌù±ÚÉú³¤Âð£¿ÓÐûÓÐÏà¹ØÎÄÏ×ÖÐÉæ¼°µ½Ïà¹ØÏ¸°û³ÉÏñͼ¡£Ð»Ð»£¡±¾È˼±Ð裡 |
» ²ÂÄãϲ»¶
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ150È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
ÇâÑõ»¯¼Ø»î»¯²Ù×÷
ÒѾÓÐ18È˻ظ´
É¢½ð
ÒѾÓÐ68È˻ظ´
ÉúÎïÖʳ¬¼¶µçÈÝÆ÷
ÒѾÓÐ0È˻ظ´
fengtingti
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.6
- É¢½ð: 25
- ºì»¨: 2
- Ìû×Ó: 239
- ÔÚÏß: 102.4Сʱ
- ³æºÅ: 600764
- ×¢²á: 2008-09-12
- ÐÔ±ð: MM
- רҵ: ¹âÆ×·ÖÎö
2Â¥2012-12-21 20:26:54









»Ø¸´´ËÂ¥
28